DOCSLIB.ORG

LC/MS/MS Method Package for Primary Metabolites Ver.3

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
LC/MS/MS Method Package for Primary Metabolites Ver.3 L C146-E437 C/MS/MS Method Package for Primary Metabolites Ver.3 List of compounds for the non-ion-pair reagent method system lytic Glyco- Organic acids Co-enzyme Lactic acid 2-Aminobutyric acid FAD Pyruvic acid 4-Aminobenzoic acid FMN cycle TCA 4-Aminobutyric acid NAD 2-Ketoglutaric acid Caffeic acid Niacinamide Aconitic acid Cholic acid Nicotinic acid Citric acid Creatine Fumaric acid Ferulic acid pathway acid mevalonic Non- Isocitric acid Glycolic acid DOXP Malic acid Glyoxylic acid MEP Succinic acid Ophthalmic acid cycle Urea Orotic acid pathway acid Mevalonic For LabSolutions LCMS Argininosuccinic acid p-Coumaric acid Mevalonic acid Ornithine Phenyllactic acid MVA-P Citrulline Amino acids Phenylpyruvic acid 4-Hydroxyproline Alkaloid Taurocholic acid LC/MS/MS Method Package Alanine Higenamine Urocanic acid Anthranilic acid Reticuline Vanillic acid Arginine THP lamine Catecho- Asparagine Dopamine Aspartic acid Others for Primary Metabolites Ver.3 Epinephrine 4-Aminophenylalanine Asymmetric dimethylarginine Norepinephrine 4-Aminophenylpyruvic acid Cystine Serotonin Dimethylglycine 4-Hydroxybenzoic acid Vitamin B Glutamic acid Folic acid Acetylcarnitine Glutamine Pantothenic acid Acetylcholine Glycine PLP Carnitine Histidine Nucleosides and Nucleotides Carnosine Homocystine Adenine Catechol Isoleucine Adenosine Choline Leucine Adenosine 3',5'-cyclic monophosphate Citicoline Lysine Adenosine monophosphate Creatinine Methionine sulfoxide Adenylsuccinic acid Cysteamine Phenylalanine AICAR Dihydroxyphenylacetaldehyde Proline Cytidine Dihydroxyphenylacetic acid Serine Cytidine 3',5'-cyclic monophosphate Dopa Symmetric dimethylarginine Cytidine monophosphate Ergothioneine Threonine Cytosine Histamine Tryptophan Guanine Histidinol Valine Guanosine Hydroxytyrosol Transsulfuration cycle Methylation and Cystathionine Guanosine 3',5'-cyclic monophosphate Indole Cysteine Guanosine monophosphate Kynurenine Homocysteine Inosine Methyl-DOPA Methionine Thymidine Protocatechuic acid 5-Glutamylcysteine Thymidine monophosphate Protocatechuic aldehyde Glutathione Thymine Resveratrol Oxidized glutathione Tyrosine Salicylic acid S-Adenosylhomocysteine Uracil Sinapic acid S-Adenosylmethionine Uridine Tyramine derivative Purine Vanillin pathway Shikimic acid 3-Dehydroquinic acid Allantoin 3-Dehydroshikimic acid Hypoxanthine STDs Internal 2-Morpholinoethanesulfonic acid Chorismic acid Uric acid Methionine sulfone Shikimic acid Xanthine Shikimic acid 3-phosphate * With this method package, choose between the ion-pair reagent method (112 compounds) or the PFPP column method (141 compounds) depending on your equipment and analysis aims. Precautions LabSolutions LCMS Ver.5.99 SP2 or later is required. This method package is for research use only. LabSolutions and Nexera are trademarks of Shimadzu Corporation. GARUDA is a trademark of The Systems Biology Institute. For Research Use Only. Not for use in diagnostic procedures. This publication may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country. Company names, products/service names and logos used in this publication are trademarks and trade names of Shimadzu Corporation, its subsidiaries or its afliates, whether or not they are used with trademark symbol “TM” or “®”. Third-party trademarks and trade names may be used in this publication to refer to either the entities or their products/services, whether or not they are used with trademark symbol “TM” or “®”. Shimadzu disclaims any proprietary interest in trademarks and trade names other than its own. www.shimadzu.com/an/ The contents of this publication are provided to you “as is” without warranty of any kind, and are subject to change without notice. Shimadzu does not assume any responsibility or liability for any damage, whether direct or indirect, relating to the use of this publication. © Shimadzu Corporation, 2021 / First Edition: May 2021, 3655-04102-PDFIK, C146-E437 Ready-to-use methods for 200 compounds Compatible with the Nexera™ series and the LCMS-8060NX This Method Package enables efcient, simultaneous analysis of a large number of compounds. Optimized LC All methods are compatible with both the Nexera series and the LCMS-8045/8050/8060 (NX), covering a wide separation conditions and MS parameters reduce the time and effort expended on method development. range of analysis needs. Choice of optimized analysis conditions A total solution from pretreatment to analysis Choose between two method types to suit your analysis aims and equipment. The ion-pair reagent method This Method Package includes protocols for preparing biological tissue extracts, enabling stable analysis with (112 compounds) is particularly useful for the analysis of sugar phosphates, while the non-ion-pair reagent proven pretreatment techniques and reducing the labor and expense involved in method development. method (141 compounds), effective in the research of high-value-added substances, does not require ion-pair reagents and in this version has been expanded to include compounds involved in the mevalonate and shikimic acid pathways. Index of compounds 14000000 13000000 List of compounds for the ion-pair reagent method 12000000 Glycolytic system Co-enzyme Nucleosides and Nucleotides 11000000 2,3-Bisphosphoglyceric acid 3-Hydroxybutyryl coenzyme A Adenine 10000000 3-Phosphoglyceric acid Butyryl coenzyme A Adenosine 9000000 (2-Phosphoglyceric acid) Coenzyme A Adenosine 3',5'-cyclic monophosphate 8000000 Dihydroxyacetone phosphate Crotonyl coenzyme A Adenosine diphosphate 7000000 Fructose 1,6-bisphosphate FAD Adenosine monophosphate 6000000 Glucose 1-phosphate FMN Adenosine triphosphate 5000000 Glucose 6-phosphate Malonyl coenzyme A AICAR 4000000 Glycerol 3-phosphate Methylmalonyl coenzyme A Cytidine 3000000 Phosphoenolpyruvic acid NAD Cytidine diphosphate Pyruvic acid NADH Cytidine monophosphate 2000000 phate pathway Pentose-phos Fructose 6-phosphate NADP Cytidine triphosphate 1000000 Glyceraldehyde 3-phosphate NADPH Guanine 0 6-Phosphogluconic acid Nicotinic acid Guanosine 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 min Erythrose 4-phosphate Pyrroloquinoline quinone Guanosine 3',5'-cyclic monophosphate Ribose 1-phosphate pathway acid mevalonic Non- Guanosine diphosphate Overlaid MRM chromatograms for simultaneous analysis of a mixture of 141 standards with the non-ion-pair reagent method Ribose 5-phosphate HMBPP Guanosine monophosphate Ribulose 5-phosphate IPP_DMAPP Guanosine triphosphate Sedoheptulose 7-phosphate MEP Inosine pathway acid Shikimic phosphate Sugar Inosine monophosphate Fructose 1-phosphate Shikimic acid Orotic acid Mannose 6-phosphate Shikimic acid 3-phosphate Thymidine Visualization of metabolic changes Phosphoribosyl pyrophosphate Thymidine diphosphate Ribulose 1,5-bisphosphate Organic acids 2-Isopropylmalic acid Thymidine monophosphate cycle TCA Thymidine triphosphate With the included Multi-omics Data Analysis Package, quantitative data can be visualized easily on a meta- Acetyl coenzyme A 3-Hydroxyphenylacetic acid Thymine 2-Ketoglutaric acid 4-Hydroxyphenyl pyruvic acid bolic map. Uridine Succinyl coenzyme A Citramalic acid Glyceric acid Uridine diphosphate Amino acids 8000000 20000000 7000000 17500000 2-Aminobutyric acid Glycerol 2-phosphate Uridine monophosphate 6000000 15000000 5000000 12500000 4-Aminobutyric acid Glycerol 3-phosphate Uridine triphosphate 4000000 10000000 3000000 7500000 Alanine Glycolic acid Xanthosine monophosphate 2000000 5000000 1000000 2500000 sugar Nucleotide 0 0 Arginine Indole 3-acetic acid 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 min 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 min Asparagine Pantothenic acid ADP-glucose Aspartic acid UDP-glucose Cysteine Glutamic acid Glutamine derivative Purine Hypoxanthine Glycine Uric acid Histidine Xanthine 4-Hydroxyproline Isoleucine STDs Internal Leucine 2-Morpholinoethanesulfonic acid Lysine Methionine sulfone Methionine Phenylalanine Proline Serine Threonine Tryptophan Tyrosine Valine http://www.garuda-alliance.org/ Visualization of simultaneous analysis results from the PFPP column method, created with the Multi-omics Data Analysis Package Ready-to-use methods for 200 compounds Compatible with the Nexera™ series and the LCMS-8060NX This Method Package enables efcient, simultaneous analysis of a large number of compounds. Optimized LC All methods are compatible with both the Nexera series and the LCMS-8045/8050/8060 (NX), covering a wide separation conditions and MS parameters reduce the time and effort expended on method development. range of analysis needs. Choice of optimized analysis conditions A total solution from pretreatment to analysis Choose between two method types to suit your analysis aims and equipment. The ion-pair reagent method This Method Package includes protocols for preparing biological tissue extracts, enabling stable analysis with (112 compounds) is particularly useful for the analysis of sugar phosphates, while the non-ion-pair reagent proven pretreatment techniques and reducing the labor and expense involved in method development. method (141 compounds), effective in the research of high-value-added substances, does not require ion-pair reagents and in this version has been expanded to include compounds involved in the mevalonate and shikimic acid pathways. Index of compounds 14000000 13000000 List of compounds for the ion-pair reagent method 12000000 Glycolytic
Load more

Recommended publications
  • University Microfilms International 300 N
    INFORMATION TO USERS This was produced from a copy of a document sent to us for microfilming. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the material submitted. The following explanation of techniques is provided to help you understand markings or notations which may appear on this reproduction. 1. The sign or "target” for pages apparently lacking from the document photographed is "Missing Page(s)”. If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting through an image and duplicating adjacent pages to assure you of complete continuity. 2. When an image on the film is obliterated with a round black mark it is an indication that the film inspector noticed either blurred copy because of movement during exposure, or duplicate copy. Unless we meant to delete copyrighted materials that should not have been filmed, you will find a good image of the page in the adjacent frame. If copyrighted materials were deleted you will find a target note listing the pages in the adjacent frame. 3. When a map, drawing or chart, etc., is part of the material being photo­ graphed the photographer has followed a definite method in “sectioning” the material. It is customary to begin filming at the upper left hand corner of a large sheet and to continue from left to right in equal sections with small overlaps. If necessary, sectioning is continued again—beginning below the first row and continuing on until complete.
    [Show full text]
  • Monosaccharides and Their Derivatives in Carbonaceous Meteorites: a Scenario for Their Synthesis and Onset of Enantiomeric Excesses
    life Review Monosaccharides and Their Derivatives in Carbonaceous Meteorites: A Scenario for Their Synthesis and Onset of Enantiomeric Excesses George Cooper 1,*, Andro C. Rios 1,2,* and Michel Nuevo 1,3 ID 1 NASA-Ames Research Center, Moffett Field, CA 94035, USA; [email protected] 2 Blue Marble Space, 1001 4th Ave, Ste 3201, Seattle, WA 98154, USA 3 Bay Area Environmental Research Institute, NASA Research Park, Moffett Field, CA 94035, USA * Correspondence: [email protected] (G.C.); [email protected] (A.C.R.) Received: 5 June 2018; Accepted: 22 August 2018; Published: 27 August 2018 Abstract: Carbonaceous meteorites provide the best glimpse into the solar system’s earliest physical and chemical processes. These ancient objects, ~4.56 billion years old, contain evidence of phenomena ranging from solar system formation to the synthesis of organic compounds by aqueous and (likely) low-temperature photolytic reactions. Collectively, chemical reactions resulted in an insoluble kerogen-like carbon phase and a complex mixture of discrete soluble compounds including amino acids, nucleobases, and monosaccharide (or “sugar”) derivatives. This review presents the documented search for sugars and their derivatives in carbonaceous meteorites. We examine early papers, published in the early 1960s, and note the analytical methods used for meteorite analysis as well as conclusions on the results. We then present the recent finding of sugar derivatives including sugar alcohols and several sugar acids: The latter compounds were found to possess unusual “D” enantiomeric (mirror-image) excesses. After discussions on the possible roles of interstellar grain chemistry and meteorite parent body aqueous activity in the synthesis of sugar derivatives, we present a scenario that suggests that most of Earth’s extraterrestrial sugar alcohols (e.g., glycerol) were synthesized by interstellar irradiation and/or cold grain chemistry and that the early solar disk was the location of the initial enantiomeric excesses in meteoritic sugar derivatives.
    [Show full text]
  • 35 Disorders of Purine and Pyrimidine Metabolism
    35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP).
    [Show full text]
  • Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide
    ICANCER RESEARCH 26 Part 1, 1466-1472,July 1966] Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic Acid Synthetase System of Sensitive and Resistant Plasmacytomas1 ARTHUR J. TOMISEK, MARTHA BRUCE IRICK, AND PAULA WEDELES ALLAN Kettering'-Meyer Laboratory,2 Southern Research Institute, Birmingham, Alabama Summary term DNA-synthetase. In addition to this measurement of over-all DNA synthetase activity, we used the same experiments We have shown that the in vivo treatment of Fortner plasma- to determine the time course of radioactivity distribution among cytomas with Cyclophosphamide can lead to strong inhibitions of both deoxyribonucleic acid nucleotidyl transferase and thymi- the soluble components of the synthetase reaction mixtures. Our data show that the observed decreases in enzyme activity dylatc kinase activities in the soluble cell fractions. However, in are among the possible consequences of growth inhibition in the allowing only 2 hr for the inhibitor to act, the effect observed on tumor. the transferase was an unexplained stimulation rather than an inhibition. We have also provided some evidence that the inhibition of Materials and Methods growth precedes the inhibition of deoxyribonucleic acid nucleo ENZYME PREPARATION.Fortner hamster plasmacytoma tidyl transferase activity. ("sensitive") (3) and ite cyclophosphamide-resistant subline (12) were used for bilateral s.c. implantation into groups of 6-12 Introduction Golden Syrian hamsters, the animals in each experiment being uniform with respect to commercial subline, sex, and approxi Previous studies in this laboratory have shown that several mate age. On the 12th-14th postimplant day the animals were alkylating agents inhibited the in vivo synthesis of DNA by divided into 2 subgroups, to receive daily i.p.
    [Show full text]
  • WO 2013/153359 Al 17 October 2013 (17.10.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/153359 Al 17 October 2013 (17.10.2013) P O P C T (51) International Patent Classification: Edmund Cartwright House, 4 Robert Robinson Avenue, C07K 14/435 (2006.01) C12Q 1/00 (2006.01) Oxford Science Park, Oxford Oxfordshire OX4 4GA (GB). (21) International Application Number: (74) Agent: CHAPMAN, Lee Phillip; 14 South Square, Gray's PCT/GB20 13/050667 Inn, London Greater London WC1R 5JJ (GB). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 15 March 2013 (15.03.2013) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (25) Filing Language: English BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (26) Publication Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (30) Priority Data: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 61/622,174 10 April 2012 (10.04.2012) US ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (71) Applicant: OXFORD NANOPORE TECHNOLOGIES NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, LIMITED [GB/GB]; Edmund Cartwright House, 4 Robert RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, Robinson Avenue, Oxford Science Park, Oxford Oxford TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, shire OX4 4GA (GB).
    [Show full text]
  • Utilisation Des Cellules Souches Pluripotentes Pour Le Criblage À Haut Débit De Molécules Thérapeutiques
    Utilisation des cellules souches pluripotentes pour le criblage à haut débit de molécules thérapeutiques dans la maladie de Lesch-Nyhan : 2019SACLE011 NNT Thèse de doctorat de l'Université Paris-Saclay, préparée à l’Université d’Evry Val-d’Essonne École doctorale n°569 Innovation thérapeutique : du fondamental à l’appliqué (ITFA) Spécialité de doctorat: Immunologie Thèse présentée et soutenue à Corbeil-Essonnes, le 01 juillet 2019, par Valentin Ruillier Composition du Jury : Dr. Olivier Goureau Institut de la Vision, Université Sorbonne, Paris Président Pr. Odile Boespflug-Tanguy Université Paris Diderot, Hôpital Robert Debré, Paris Rapporteur Dr. Amélie Piton IGBMC, Hôpitaux Universitaires de Strasbourg Rapporteur Dr. Terence Beghyn APTEEUS, Lille Examinateur Pr. Christelle Monville UEVE/INSERM U861, I-STEM, Corbeil-Essonnes Directeur de thèse Dr. Alexandra Benchoua CECS, I-STEM, Corbeil-Essonnes Co-Encadrant Résumé - Abstract Mots clés : Maladie de Lesch-Nyhan, cellules souches pluripotentes, iPSC, criblage à haut débit, HGPRT, purines Résumé : Les mutations affectant la fonction identifier, par une approche de criblage à haut d’enzymes impliquées dans le cycle des purines débit, de nouvelles molécules chimiques capables sont responsables d’une multitude de syndromes de corriger ces défauts. Plus de 3000 molécules pédiatriques, caractérisés par des atteintes ont été testées et 6 composés, tous dérivés de neurologiques et comportementales. A ce jour, l’adénosine, ont pu être identifiés comme aucune stratégie thérapeutique n’a été compensant le métabolisme par un mécanisme réellement efficace pour contrôler ces d’action indépendant de l’HGPRT. De manière symptômes. La maladie de Lesch-Nyhan (MLN), intéressante, un des composés, la S- associée à la perte de fonction de l’enzyme de adenosylmethionine (SAM) a par le passé déjà recyclage HGPRT, constitue un bon modèle démontré des effets bénéfiques sur les d’étude.
    [Show full text]
  • Intereferents in Condensed Tannins Quantification by the Vanillin Assay
    INTEREFERENTS IN CONDENSED TANNINS QUANTIFICATION BY THE VANILLIN ASSAY IOANNA MAVRIKOU Dissertação para obtenção do Grau de Mestre em Vinifera EuroMaster – European Master of Sciences of Viticulture and Oenology Orientador: Professor Jorge Ricardo da Silva Júri: Presidente: Olga Laureano, Investigadora Coordenadora, UTL/ISA Vogais: - Antonio Morata, Professor, Universidad Politecnica de Madrid - Jorge Ricardo da Silva, Professor, UTL/ISA Lisboa, 2012 Acknowledgments First and foremost, I would like to thank the Vinifera EuroMaster consortium for giving me the opportunity to participate in the M.Sc. of Viticulture and Enology. Moreover, I would like to express my appreciation to the leading universities and the professors from all around the world for sharing their scientific knowledge and experiences with us and improving day by day the program through mobility. Furthermore, I would like to thank the ISA/UTL University of Lisbon and the personnel working in the laboratory of Enology for providing me with tools, help and a great working environment during the experimental period of this thesis. Special acknowledge to my Professor Jorge Ricardo Da Silva for tutoring me throughout my experiment, but also for the chance to think freely and go deeper to the field of phenols. Last but most important, I would like to extend my special thanks to my family and friends for being a true support and inspiration in every doubt and decision. 1 UTL/ISA University of Lisbon “Vinifera Euromaster” European Master of Science in Viticulture&Oenology Ioanna Mavrikou: Inteferents in condensed tannins quantification with vanillin assay MSc Thesis: 67 pages Key Words: Proanthocyanidins; Interference substances; Phenols; Vanillin assay Abstract Different methods have been established in order to perform accurately the quantification of the condensed tannins in various plant products and beverages.
    [Show full text]
  • Separation and Quantitation of Water Soluble Cellular Metabolites by Hydrophilic Interaction Chromatography-Tandem Mass Spectrometry Sunil U
    Journal of Chromatography A, 1125 (2006) 76–88 Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry Sunil U. Bajad a, Wenyun Lu a, Elizabeth H. Kimball a, Jie Yuan a, Celeste Peterson b, Joshua D. Rabinowitz a,∗ a Lewis-Sigler Institute for Integrative Genomics and Department of Chemistry, Princeton University, Princeton, NJ 08544, USA b Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA Received 13 January 2006; received in revised form 8 May 2006; accepted 10 May 2006 Available online 6 June 2006 Abstract A key unmet need in metabolomics is the ability to efficiently quantify a large number of known cellular metabolites. Here we present a liquid chromatography (LC)–electrospray ionization tandem mass spectrometry (ESI-MS/MS) method for reliable measurement of 141 metabolites, including components of central carbon, amino acid, and nucleotide metabolism. The selected LC approach, hydrophilic interaction chromatography with an amino column, effectively separates highly water soluble metabolites that fail to retain using standard reversed-phase chromatography. MS/MS detection is achieved by scanning through numerous selected reaction monitoring events on a triple quadrupole instrument. When applied to extracts of Escherichia coli grown in [12C]- versus [13C]glucose, the method reveals appropriate 12C- and 13C-peaks for 79 different metabolites. © 2006 Elsevier B.V. All rights reserved. Keywords: LC–ESI-MS/MS; Escherichia coli; Metabolomics; Metabonomics; Hydrophilic interaction chromatography; Bacteria; Metabolite; metabolism; Triple quadrupole; Mass spectrometry 1. Introduction pounds, likely capture most key metabolic end products and intermediates [5–8]. Thus, a key current need is an assay that The ability to quantify numerous mRNA in parallel using can reliably and efficiently measure these known compounds DNA microarrays has revolutionized biological science, with [9].
    [Show full text]
  • The Synthesis of Vanillin
    The synthesis of vanillin - learning about aspects of sustainable chemistry by comparing different syntheses La síntesis de la vainilla - aprendiendo sobre aspectos de química sostenible mediante la comparación de diferentes síntesis NICOLE GARNER1, ANTJE SIOL2 , INGO EILKS1 1 Institute for Science Education, University of Bremen, 2 Center for Environmental Research and Sustainable Technology, University of Bremen, Germany, [email protected] Abstract • Prevention This paper discusses one way of integrating the aspects of sustainable chemistry into • Atom Economy secondary and undergraduate chemistry education. Two different synthesis reactions • Less Hazardous Chemical Syntheses for vanillin are presented, which both use isoeugenol as the starting reagent. Whereas • Designing Safer Chemicals the first synthesis is performed using conventional chemistry techniques, second • Safer Solvents and Auxiliaries approach employs strategies inspired by sustainable chemistry. The discussion • Design for Energy Efficiency covers how comparison of these two experiments can aid in learning about selected • Use of Renewable Feedstocks sustainable chemistry principles. • Reduce Derivatives Key words: education for sustainable development, chemistry education, green • Catalysis chemistry, vanillin • Design for Degradation • Real-time Analysis for Pollution Prevention Resumen • Inherently Safer Chemistry for Accident Prevention Este artículo analiza una manera de integrar los aspectos de la química sostenible en la escuela secundaria y en bachillerato.
    [Show full text]
  • Reconstituted IMPDH Polymers Accommodate Both Catalytically Active and Inactive Conformations
    M BoC | BRIEF REPORT Reconstituted IMPDH polymers accommodate both catalytically active and inactive conformations Sajitha A. Anthonya,†, Anika L. Burrellb,†, Matthew C. Johnsonb, Krisna C. Duong-Lya, Yin-Ming Kuoa, Jacqueline C. Simoneta, Peter Michenerc, Andrew Andrewsa, Justin M. Kollmanb,†,*, and Jeffrey R. Petersona,†,* aCancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111; bDepartment of Biochemistry, University of Washington, Seattle, WA 98195; cDepartment of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102 ABSTRACT Several metabolic enzymes undergo reversible polymerization into macromo- Monitoring Editor lecular assemblies. The function of these assemblies is often unclear, but in some cases they Diane Barber regulate enzyme activity and metabolic homeostasis. The guanine nucleotide biosynthetic University of California, San Francisco enzyme inosine monophosphate dehydrogenase (IMPDH) forms octamers that polymerize into helical chains. In mammalian cells, IMPDH filaments can associate into micron-length Received: Apr 25, 2017 assemblies. Polymerization and enzyme activity are regulated in part by binding of purine Revised: Aug 2, 2017 nucleotides to an allosteric regulatory domain. ATP promotes octamer polymerization, Accepted: Aug 4, 2017 whereas guanosine triphosphate (GTP) promotes a compact, inactive conformation whose ability to polymerize is unknown. Also unclear is whether polymerization directly alters IMPDH catalytic activity. To address this, we identified point mutants of human IMPDH2 that either prevent or promote polymerization. Unexpectedly, we found that polymerized and nonassembled forms of recombinant IMPDH have comparable catalytic activity, substrate affinity, and GTP sensitivity and validated this finding in cells. Electron microscopy revealed that substrates and allosteric nucleotides shift the equilibrium between active and inactive conformations in both the octamer and the filament.
    [Show full text]
  • Nucleotide Metabolism 22
    Nucleotide Metabolism 22 For additional ancillary materials related to this chapter, please visit thePoint. I. OVERVIEW Ribonucleoside and deoxyribonucleoside phosphates (nucleotides) are essential for all cells. Without them, neither ribonucleic acid (RNA) nor deoxyribonucleic acid (DNA) can be produced, and, therefore, proteins cannot be synthesized or cells proliferate. Nucleotides also serve as carriers of activated intermediates in the synthesis of some carbohydrates, lipids, and conjugated proteins (for example, uridine diphosphate [UDP]-glucose and cytidine diphosphate [CDP]- choline) and are structural components of several essential coenzymes, such as coenzyme A, flavin adenine dinucleotide (FAD[H2]), nicotinamide adenine dinucleotide (NAD[H]), and nicotinamide adenine dinucleotide phosphate (NADP[H]). Nucleotides, such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), serve as second messengers in signal transduction pathways. In addition, nucleotides play an important role as energy sources in the cell. Finally, nucleotides are important regulatory compounds for many of the pathways of intermediary metabolism, inhibiting or activating key enzymes. The purine and pyrimidine bases found in nucleotides can be synthesized de novo or can be obtained through salvage pathways that allow the reuse of the preformed bases resulting from normal cell turnover. [Note: Little of the purines and pyrimidines supplied by diet is utilized and is degraded instead.] II. STRUCTURE Nucleotides are composed of a nitrogenous base; a pentose monosaccharide; and one, two, or three phosphate groups. The nitrogen-containing bases belong to two families of compounds: the purines and the pyrimidines. A. Purine and pyrimidine bases Both DNA and RNA contain the same purine bases: adenine (A) and guanine (G).
    [Show full text]
  • Snapshot: Mammalian TRP Channels David E
    SnapShot: Mammalian TRP Channels David E. Clapham HHMI, Children’s Hospital, Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA TRP Activators Inhibitors Putative Interacting Proteins Proposed Functions Activation potentiated by PLC pathways Gd, La TRPC4, TRPC5, calmodulin, TRPC3, Homodimer is a purported stretch-sensitive ion channel; form C1 TRPP1, IP3Rs, caveolin-1, PMCA heteromeric ion channels with TRPC4 or TRPC5 in neurons -/- Pheromone receptor mechanism? Calmodulin, IP3R3, Enkurin, TRPC6 TRPC2 mice respond abnormally to urine-based olfactory C2 cues; pheromone sensing 2+ Diacylglycerol, [Ca ]I, activation potentiated BTP2, flufenamate, Gd, La TRPC1, calmodulin, PLCβ, PLCγ, IP3R, Potential role in vasoregulation and airway regulation C3 by PLC pathways RyR, SERCA, caveolin-1, αSNAP, NCX1 La (100 µM), calmidazolium, activation [Ca2+] , 2-APB, niflumic acid, TRPC1, TRPC5, calmodulin, PLCβ, TRPC4-/- mice have abnormalities in endothelial-based vessel C4 i potentiated by PLC pathways DIDS, La (mM) NHERF1, IP3R permeability La (100 µM), activation potentiated by PLC 2-APB, flufenamate, La (mM) TRPC1, TRPC4, calmodulin, PLCβ, No phenotype yet reported in TRPC5-/- mice; potentially C5 pathways, nitric oxide NHERF1/2, ZO-1, IP3R regulates growth cones and neurite extension 2+ Diacylglycerol, [Ca ]I, 20-HETE, activation 2-APB, amiloride, Cd, La, Gd Calmodulin, TRPC3, TRPC7, FKBP12 Missense mutation in human focal segmental glomerulo- C6 potentiated by PLC pathways sclerosis (FSGS); abnormal vasoregulation in TRPC6-/-
    [Show full text]